SCIENTIFIC PROGRAM – POSTER PRESENTATIONS

The files of the submitted abstracts are available for download.
Please click on the ABSTRACT CODE NUMBER to view the file and save in PDF.

SCIENTIFIC PROGRAM – POSTER SESSION 1
36 MICRORNA-9 PROMOTES PROLIFERATION OF LEUKEMIA CELLS IN ADULT CD34 POSITIVE ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE BY DOWN-REGULATION OF HES1
184 MOLECULAR ANALYSIS OF FUSION GENES ASSOCIATED WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN PEDIATRIC PATIENTS IN PARÁ STATE, BRAZIL
223 HLA-A, -B -DRB1 ALLELE AND HAPLOTYPE FREQUENCIES IN BRAZILIAN BONE MARROW DONOR VOLUNTEERS FROM THE NORTH AND SOUTHEASTERN REGIONS
295 GENOMIC PROFILE OF PATIENTS WITH TRIPLE NEGATIVE (JAK2, CALR AND MPL) ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS
298 THE PRESENCE OF ASXL1 MUTATIONS AS WELL AS A TOTAL NUMBER OF MYELOID DRIVER MUTATIONS HIGHER THAN TWO IS STRONGLY ASSOCIATED WITH THE DIAGNOSIS OF PRIMARY MYELOFIBROSIS AS OPPOSED TO ESSENTIAL THROMBOCYTHEMIA
318 PGEMOX/GELOX REGIMEN IS SUPERIOR TO NON-PGEMOX/GELOX REGIMENS IN THE TREATMENT OF PATIENTS WITH STAGE IE/IIE EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE STUDY IN A COHORT OF 599 PATIENTS
356 TAFRO SYNDROME – FIRST CASE REPORTED IN LATIN AMERICA
357 CLONAL T CELL LARGE GRANULAR LYMPHOCYTE EXPANSION FOLLOWING HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN A PATIENT WITH HODGKIN LYMPHOMA – A CASE REPORT
361 NEW RISK FACTORS AND NEW TENDENCY FOR CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
539 EWING SARCOMA VS M7 ACUTE MYELOID LEUKEMIA: A SINGLE DISEASE OR COEXISTENCE OF TWO DIFFERENT DISEASES
588 BLOOD-BORNE DENGUE VIRUS: SEVERE DENGUE CASE REPORT IN A HEMATOPOIETIC STEM CELL RECIPIENT AND REVIEW
662 THE USE OF HEPARIN PRIME FOLLOWED BY ACID-CITRATE-DEXTROSE-ADENINE (ACD-A) FOR EXTRACORPOREAL PHOTOPHERESIS (ECP) USING THE CELLEX ® INSTRUMENT.
SCIENTIFIC PROGRAM  – POSTER SESSION 2
26 NOMOGRAMS TO ESTIMATE LONG-TERM OVERALL SURVIVAL AND BREAST CANCER-SPECIFIC SURVIVAL OF PATIENTS WITH LUMINAL BREAST CANCER
33 DIFFERENT PATTERNS IN THE PROGNOSTIC VALUE OF TUMOR SIZE FOR BREAST CANCER-SPECIFIC SURVIVAL STRATIFIED BY JOINT HORMONE RECEPTOR STATUS IN A SEER POPULATION-BASED ANALYSIS
43 PACLITAXEL AND PLATINUM IS FAVOR THAN ANTHRACYCLINES FOR PATIENTS WITH HER2 NEGATIVE BREAST CANCER
44 PREDICTORS FOR THE PATHOLOGICAL COMPLETE RESPONSE OF AXILLARY LYMPH NODE METASTASIS IN PATHOLOGICALLY PROVEN NODE POSITIVE BREAST CANCER PATIENTS
47 CLINICAL PATHOLOGIC CHARACTERISTICS OF MUCINOUS BREAST CANCER: A RETROSPECTIVE ANALYSIS OF 10-YEAR STUDY
67 IN SEARCH OF THE OPTIMAL TIMING OF BREAST RECONSTRUCTION IN THE CONTEXT OF IRRADIATION: A CONSECUTIVE 370 PEDICLED TRAM/DIEP FLAPS PERFORMED IN A SINGLE CENTER
75 GENETIC EVALUATION OF BRCA1 ASSOCIATED A COMPLEX GENES WITH TRIPLE-NEGATIVE BREAST CANCER SUSCEPTIBILITY IN CHINESE WOMEN
113 CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF INVASIVE PAPILLARY CARCINOMA OF BREAST: A SEER POPULATION-BASED STUDY
128 RISK FACTORS AND CLINICAL CHARACTERISTICS OF LOCO-REGIONAL RELAPSE IN LOCAL ADVANCED BREAST CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY FOLLOWING MASTECTOMY AND RADIOTHERAPY: A SINGLE-CENTER EXPERIENCE FOR NON-PATHOLOGICAL COMPLETE RESPONDERS
129 THE PHOSPHORYLATION-SPECIFIC ASSOCIATION OF STMN1 WITH GRP78 PROMOTES METASTASIS IN BREAST CANCER
190 ASPECTS OF IMAGE OF RADIAL SCAR / COMPLEX SCLEROSING LESION
191 SUPPORTING MRI IN SURGICAL PLANNING OF BREAST CANCER
192 THE ROLE OF MRI IN THE EVALUATION OF COMPROMISED SURGICAL MARGINS AND POSTOPERATIVE RESIDUAL DISEASE OF BREAST CANCER
218 LOW RATE OF POSITIVE MARGINS AND REEXCISION AFTER PARTIAL MASTECTOMY IN HIGHLY SELECTIVE BREAST CANCER PATIENTS:A CHINESE SINGLE-INSTITUTION EXPERIENCE
237 SELECTIVE SENTINEL LYMPH NODE AFTER NEOADJUVANT SYSTEMIC THERAPY ACCORDING TO ALTERATION OF 18FDG PET/CT UPTAKE IN AXILLA AND MOLECULAR SUBTYPE IN NODE POSITIVE BREAST CANCER: A PILOT STUDY
250 METAPLASTIC BREAST CARCINOMA: WHAT THE ONCOLOGY TEAM SHOULD KNOW.
292 DIVERSE ROLE OF HOMEOSTATIC MUCOSA-ASSOCIATED CHEMOKINES IN BREAST CANCER
342 TUMOR SIZE IN BREAST INVASIVE DUCTAL CANCER AND THEIR RELATION TO CLINIC PATHOLOGIC CHARACTERISTICS, MOLECULAR MARKERS
366 RGD-CONJUGATED MESOPOROUS SILICA-ENCAPSULATED GOLD NANORODS ENHANCE THE SENSITIZATION OF TRIPLE-NEGATIVE BREAST CANCER TO MEGAVOLTAGE RADIATION THERAPY
368 ROLE OF BREAST MRI IN THE EVALUATION OF DUCTAL CARCINOMA IN SITU.
404 METAPLASTIC CARCINOMA OF THE BREAST: HOW DO THEY PRESENT AT IMAGING STUDIES?
429 EVALUATION OF SUSPICIOUS BREAST CALCIFICATIONS WITH POSITRON EMISSION MAMMOGRAPHY (PEM).
446 SINGLE INSTITUTION ASSESSMENT OF PATHOGENIC BRCA1 MUTATION IN TRIPLE NEGATIVE BREAST CANCER AND ITS ASSOCIATION WITH CLINICAL FEATURES AND TREATMENT RESPONSE
62 THE PREOPERATIVE SUVMAX FOR 18F-FDG UPTAKE PREDICTS SURVIVAL IN PATIENTS WITH COLORECTAL CANCER
77 EXAMINING PLASMA MICRORNA MARKERS FOR COLORECTAL CANCER AT DIFFERENT STAGES
141 INHIBIT THE FUNCTION OF SREBP1 POSSIBOLLY PROMOTE APOPTOSIS AND 5-FU SENSITIVITY OF COLORECTAL CANCER
167 GAS1: EPITHELIAL-MESENCHYMAL TRANSITION AND WARBURG EFFECT INHIBITOR IN COLORECTAL CARCINOMA
176 MIR-590-5P INHIBITS COLORECTAL CANCER ANGIOGENESIS AND METASTASIS BY REGULATING NUCLEAR FACTOR 90/VASCULAR ENDOTHELIAL GROWTH FACTOR AXIS
254 RECTAL CANCER T STAGE: A COMPARATIVE STUDY TO EVALUATE PREDICTIVE ABILITY OF PET-CT AND MR
293 TISSUE-ASSOCIATED BACTERIAL ALTERATIONS IN EARLY-STAGE RECTAL CARCINOMA PATIENTS REVEALED BY 16S RRNA COMMUNITY PROFILING
304 A RANDOMIZED TRIAL OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR COLORECTAL CANCER IN OPERATION RELATED COMPLICATIONS
333 EXPRESSION OF FOXP3 AND PROGNOSTIC SIGNIFICANCE IN COLORECTAL CANCER
351 HIGH ARG-1 EXPRESSION IS AN INDICATOR OF POOR PROGNOSIS IN COLORECTAL CANCER PATIENTS
405 LOCOREGIONAL RESTAGING OF RECTAL CANCER BY MAGNETIC RESSONANTE IMAGING IN PATIENTS SUBMITTED TO NEOADJUVANT CHEMORADIORHERAPY: PICTORIAL ESSAY
443 RAB5C ENHANCES RESISTANCE TO IONIZING RADIATION IN RECTAL CANCER
548 CT-GUIDED PREOPERATIVE LOCALIZATION OF LIVER METASTASIS OF COLORECTAL CANCER USING METAL CLIPS – A CHEAPER AND MORE EFFICIENT WAY TO REDUCE MORBIDITY AND RESIDUAL LESIONS
552 ASSOCIATION BETWEEN THE FINDINGS OF THE PROXIMAL AND DISTAL COLON DETECTED BY COLONOSCOPY: PERSPECTIVE OF THE USE OF SIGMOIDOSCOPY FOR COLORECTAL CANCER SCREENING
554 SAFETY AND EFFICIENCY OF IMAGE-GUIDED CRYOABLATION IN UNRESECTABLE PELVIC RECURRENT COLORECTAL CANCER
574 MUTATIONAL ANALYSIS OF KRAS AND BRAF IN SYNCHRONOUS AND MULTIPLE COLORECTAL LESIONS IN THE SAME PATIENT.
599 REALISTIC SIMULATION USING HIGH FIDELITY MANIKIN IN POST OPERATIVE STATE OF RECTAL SIGMOIDECTOMY: AN EVIDENCE BASED PRACTICE INTEGRATING TEACHINGS TO CLINICAL PICTURE OF COMPLICATIONS
651 CURCUMIN INHIBITS TUMOR EPITHELIAL-MESENCHYMAL TRANSITION (EMT) VIA DOWN-REGULATING WNT SIGNALING PATHWAY THROUGH UP-REGULATING NKD2 EXPRESSING IN COLON CANCER CELL
28 DOWN-REGULATION OF CDKN3 INHIBITED PROSTATE CANCER PROLIFERATION IN VITRO AND IN VIVO VIA REGULATING CELL CYCLE AND DNA REPLICATION SIGNALING
50 PATIENTS CHARACTERISTICS AND TREATMENT OUTCOME OF ORGAN CONFINED PROSTATE CANCER : KHCC EXPERIENCE
53 CARDIAC COMORBIDITIES IN EARLY STAGE PROSTATE CANCER IN ACTIVE SURVEILLANCE
97 GENETIC VARIANTS OF THE CYP1B1 GENE AS PREDICTORS OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN LOCALIZED PROSTATE CANCER PATIENTS
258 COMPARISON OF APPARENT DIFFUSION COEFFICIENT VALUES BETWEEN NORMAL PROSTATIC TISSUE AND CLINICALLY SIGNIFICANT PROSTATE CANCER WITH DIFFERENT GLEASON SCORES IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY
259 PROSTATIC TUMORS BEYOND ADENOCARCINOMAS ON MULTIPARAMETRIC MRI
320 MR GUIDED PROSTATE BIOPSY – INITIAL EXPERIENCE AT BANNER MD ANDERSON CANCER CENTER
373 INCREMENTAL DIAGNOSTIC VALUE OF US-MRI TARGETED PROSTATIC BIOPSY VERSUS RANDOM BIOPSY: A PROSPECTIVE STUDY
390 IMPACT OF PATHOLOGY REVIEW FOR DECISION THERAPY IN A MULTI-DISCIPLINARY CLINIC OF LOCALIZED PROSTATE CANCER
400 CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH CANCER WHO HAVE A SINGLE KIDNEY SUBMITTED TO COMPUTED TOMOGRAPHY, BEFORE AND AFTER INJECTION OF CONTRAST MEDIA IODINATED
415 NADIR PSA ALONE OR IN COMBINATION WITH BASELINE PSA IMPROVES PREDICTION OF TREATMENT OUTCOME IN INTERMEDIATE AND HIGH RISK LOCALIZED PROSTATE CANCER PATIENTS TREATED BY DEFINITIVE EXTERNAL BEAM RADIOTHERAPY WITH ANDROGEN DEPRIVATION.
474 INDICATIONS OF MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER.
621 GIANT ADRENAL CARCINOMA ASSOCIATED WITH VENA CAVA INVASION: CASE REPORT
260 THE VALIDATION OF IMMUNOHISTOCHEMICAL TEST TO IDENTIFY BRAF MUTATION IN MELANOMAS
386 MICROMETASTASIS IN LYMPH NODE DIAGNOSED BY IMMUNOHISTOCHEMICAL EXAM ONLY IS REALLY SIGNIFICANT. CASE REPORT.
519 MOLECULAR PROFILING, INCLUDING TERT PROMOTER MUTATIONS, OF ACRAL LENTIGINOUS MELANOMAS
594 DIGITAL PATHOLOGY OF CUTANEOUS MALIGNANT MELANOMA BY SPATIAL TRANSCRIPTOMICS
SCIENTIFIC PROGRAM  – POSTER SESSION 3
164 EFFECT OF RADIATION ON GLUCOSE METABOLISM IN BREAST CANCER CELLS CULTURED UNDER HYPOXIC CONDITION
232 ANALYSIS OF INTER-FRACTION SETUP ERROR OF NASOPHARYNGEAL CARCINOMA TREATED WITH TOMOTHERAPY WITH MEGAVOLT COMPUTED TOMOGRAPHY
240 A COMPARISON OF S1 AND S1 WITH NEDAPLATIN IN DEFINITIVE CHEMORADIATION IN UNRESECTABLE LOCALLY ADVANCED THORACIC ESOPHAGEAL CANCER PATIENTS
521 EVALUATION OF CT GUIDED BIOPSY OF ABDOMINAL CAVITY LESIONS
538 HOW TO DEVELOP A SUCCESSFUL RADIATION ONCOLOGY RESIDENCY PROGRAM IN A DEVELOPING COUNTRY WITH CONSTRAINED ECONOMY
557 PERCUTANEOUS IMPLANTATION OF FIDUCIAL MARKERS FOR IMAGING GUIDED
352 ESTABLISHMENT AND CHARACTERIZATION OF GENE KNOCKOUT TUMOR CELL LINES BY CRISPR/CAS9
440 SIGNER: SIGNATURE FINDER FOR MUTATIONAL PROCESSES IN CANCER GENOMES
461 AUTOMATIC DETECTION AND CLASSIFICATION OF CELL NUCLEI IN IMMUNOHISTOCHEMICAL IMAGES WITH ESTROGENE RECEPTOR MARKER
644 OCULAR SIDE EFFECTS WITH USE OF BIOLOGICAL THERAPY IN PATIENTS WITH CANCER
80 PROJECT ECHO TELEMENTORING TO IMPROVE CERVICAL CANCER PREVENTION AND TREATMENT IN MEDICALLY UNDERSERVED AREAS
123 THE VOLUME-METABOLIC COMBINED PARAMETERS FROM 18F-FDG PET/CT MAY HELP PREDICT THE OUTCOMES OF CERVICAL CARCINOMA
194 CYTOLOGIC FINDINGS AND REPRODUCIBILITY OF CERVICAL-VAGINAL CYTOLOGIC ABNORMALITIES AFTER TREATMENT WITH PELVIC RADIOTHERAPY FOR CERVICAL CANCER.
269 A NEW CLINICALLY APPLICABLE AGE-SPECIFIC COMORBIDITY INDEX BASED ON SELF-REPORTED INFORMATION FOR PREOPERATIVE RISK ASSESSMENT OF OVARIAN CANCER PATIENTS
288 CORILAGIN, A PROMISING COMPLIMENTARY HERBAL AGENT FOR OVARIAN CANCER THERAPY
399 DIFFERENTIAL EXPRESSION OF MICRORNAS IN UTERINE LEIOMYOSARCOMA
417 BRAZILIAN PLATFORM FOR BIOPROSPECTING STUDIES OF NATURAL COMPOUNDS WITH ANTICANCER POTENTIAL IN PRE-CLINICAL PHASE: FIRST RESULTS
449 RNA INTERFERENCE-MEDIATED TARGETING OF CTNNB1 GENE EXPRESSION IN VULVA CARCINOMA CELLS CAUSES INCREASED TUMOR CELL INVASION AND MIGRATION
628 NEOADJUVANT CHEMOTHERAPY PLUS RADICAL HYSTERECTOMY VERSUS CHEMORADIATION FOR STAGE IB2 CERVICAL CANCER: THE INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS (INEN) – PERÚ EXPERIENCE
632 PROGNOSTIC FACTORS AND ROLE OF DEBULKING SURGERY IN CHEMOREFRACTORY OVARIAN GERM CELL MALIGNANCIES: A STUDY IN CHINESE PATIENTS
635 ABDOMINAL RADICAL TRACHELECTOMY (ART): WHAT’S THE ROLE IN FERTILITY-SPARING SURGERY FOR CERVICAL MALIGNANCIES?
246 POPULATION-BASED SCREENING OF AT-RISK WOMEN FOR HEREDITARY BREAST AND COLORECTAL CANCER IN BRAZIL USING A THREE-QUESTION QUESTIONNAIRE
283 GENETIC AND EPIGENETIC CHARACTERIZATION OF THE BRCA1 GENE IN BRAZILIAN WOMEN AT-RISK FOR HEREDITARY BREAST CANCER
354 SILENCING OF GENES MAPPED ON 7Q ARE CANDIDATES TO BE ASSOCIATED WITH MULTIPLE PRIMARY TUMORS INCLUDING TRIPLE NEGATIVE BREAST CANCER
416 A CORRELATION BETWEEN BRAZILIAN HISTORY AND THE R337H MUTATION IN TP53 GENE.
445 SEARCHING FOR NEW GENES ASSOCIATED TO HEREDITARY BREAST CANCER USING WHOLE EXOME SEQUENCING
487 TREATMENT OUTCOME OF NEUROFIBROMATOSIS TYPE 1 ASSOCIATED AND SPORADIC MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
507 SEARCHING FOR NEW GENES ASSOCIATED TO HEREDITARY BREAST CANCER USING WHOLE EXOME SEQUENCING.
508 CANCER GENETIC RISK ASSESSMENT IN PEDIATRIC ONCOLOGY: RESULTS AND CHALLENGES OF A BRAZILIAN EXPERIENCE
195 INVESTIGATION OF OSTEOSARCOMA GENOMICS AND ITS IMPACT ON TARGETED THERAPY
227 FUNCTIONAL ROLE AND CLINICAL IMPACT OF KIT GNNK+ AND GNNK- ISOFORMS IN GLIOBLASTOMA
336 WHOLE GENOME SEQUENCING (WGS) OF BRAZILIAN MELANOMA PATIENTS AS PART OF THE INTERNATIONAL CANCER GENOME CONSORTIUM.
369 PROGNOSTIC VALUE OF DNA DAMAGE INDUCIBLE TRANSCRIPT 4 GENE (DDIT4) IN VARIOUS CANCERS: IN SILICO EVALUATION
409 PHENOTYPICAL AND MOLECULAR CHARACTERIZATION OF CELL CULTURES DERIVED FROM USUAL PENILE CARCINOMAS
537 ANTI-CD20 (RITUXIMAB) AS THE SOLE TREATMENT FOR PTLD (POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE)
608 IN VITRO CYTOTOXICITY OF ALLITINIB, AN IRREVERSIBLE ANTI-EGFR AGENT, IN A LARGE PANEL OF HUMAN CANCER CELL LINES: KRAS MUTATION STATUS AS A PREDICTIVE BIOMARKER
614 DESENSITIZATION PROTOCOL WITH ANTI CD20 IN A CHILD WITH SECONDARY LYMPHOPROLIFERATIVE DISEASE
646 WEB-BASED REPORTED OUTCOMES MONITORING AMONG FILIPINO CANCER PATIENTS: A CROSS-SECTIONAL ANAYLSIS OF NEEDS, ACCEPTANCE AND READINESS
656 ISSUES OF GENETIC MODIFICATION IN HUMAN EMBRYO AND ITS FUTURE ORIENTATION
287 PROGNOSTIC VALUE OF IMMUNOPHENOTYPING LYMPHOID SUBPOPULATIONS IN INVASIVE VULVA CARCINOMA
501 STANDARDS OF LOCOREGIONAL RECURRENCE OF GYNAECOLOGICAL NEOPLASMS IN RESONANCE: PICTORIAL ESSAY.
SCIENTIFIC PROGRAM – POSTER SESSION 4
32 CIRCULATORY MEDIASTINAL VACUUM DRAINAGE THERAPY AND ENDOSCOPIC BIOMEDICAL FIBRIN GLUE OCCLUSION: TWO INDIVIDUALIZED METHODS FOR ANASTOMOTIC LEAKAGE AFTER ESOPHAGEAL RESECTION
39 ROLE OF PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY TARGET BIOPSY FOR THE MOLECULAR AND HISTOPATHOLOGICAL STUDY OF GASTRIC CANCER
61 COMBINATION TREATMENT WITH TRANSCATHETERARTERIAL CHEMOEMBOLIZATION AND CRYOABLATION FOR UNRESECTABLE PRIMARY LIVER CANCER WITH TUMOR SIZE >5CM
68 A NOVEL SYSTEMIC INFLAMMATION RESPONSE INDEX (SIRI) FOR PREDICTING THE RESPONSE OF PANCREATIC CANCER TO CHEMOTHERAPY
78 RESPONSE EVALUATION IN ESOPHAGEAL CANCERS, OF NEOADJUVANT CHEMOTHERAPY USING RECIST CRITERIA ON MDCT AND TO CORRELATE IMAGING RESPONSE WITH HISTOPATHOLOGY SEEN IN POSTOPERATIVE SPECIMEN
89 EXPRESSION OF PROGRAMMED CELL DEATH LIGAND 1 (PDL1) AND XIAP IN CHINESE ESOPHAGUS SQUAMOUS CELL CARCINOMA PATIENTS
94 COMPARISON OF SURGERY PLUS CHEMOTHERAPY AND PALLIATIVE CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER WITH SYNCHRONOUS OVARIAN METASTASES
95 SAFETY AND EFFICACY OF S-1 IN ADVANCED HEPATOCELLULAR CARCINOMA
107 EVALUATION OF TUMOR MET AND HER2 EXPRESSION IN PRIMARY AND METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION (G/GEJ) CANCER
142 PROGNOSTIC FACTORS AND CLINICAL CHARACTERISTICS FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH BENIGN ENLARGED PERIHEPATIC LYMPH NODES: A SINGLE-CENTER EXPERIENCE FROM CHINA
144 ANALYSIS OF PROGNOSTIC FACTORS FOR CENTRALLY LOCATED HEPATOCELLULAR CARCINOMA: HIGH RISK, MID RISK, AND LOW RISK:A PILOT STUDY IN A SINGLE CHINESE INSTITUTE
160 ALDH STEM CELLS ARE PREDICTIVE OF SURVIVAL IN PATIENTS WITH PANCREATIC ADENOCARCINOMA TREATED WITH ADJUVANT CHEMORADIATION
163 A IDENTIFICATION OF A HIGHLY RECURRENT C18ORF8-NEDD4L GENE FUSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
179 EXPRESSION AND RELEVANCE OF THE IMPACT PROTEIN IN PANCREATIC CANCER
183 TERT INCREASED TRANSCRIPTIONAL ACTIVITY AND ONCOGENIC TERT PROMOTER MUTATIONS IN GIST.
201 MICRORNA-506 PLAYS DIFFERENT ROLES IN THE DEVELOPMENT AND PROGRESSION OF PANCREATIC DUCTAL ADENOCARCINOMA
212 EVALUATION OF CHEMOSENSITIVITY FOR PATIENTS WITH ADVANCED GASTRIC CANCER BY COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST (CD-DST) AND ITS CORRELATION WITH CLINICOPATHOLOGICAL CHARACTERISTICS
216 THE RELATIONSHIP OF SURVIVAL WITH PATHOLOGIC FACTORS IN ELDERLY GASTRIC CANCER PATIENTS(≥70 YEARS)
217 HYPERMETHYLATION AT THE NDRG4 CPG ISLAND IS ASSOCIATED WITH THE RISK OF GASTRIC CANCER
229 PROGNOSTIC VALUE OF P53 FOR COLORECTAL CANCER AFTER SURGICAL RESECTION OF PULMONARY METASTASES
230 METHYLATION OF CPG ISLANDS IN THE PROMOTER REGIONS OF P16, HMLH1 AND CDH1 GENES IN PATIENTS WITH GASTRIC CANCER
243 ADVANCED HEPATOPANCREATICOBILIARY CANCER RELATED MALIGNANT BILIARY OBSTRUCTION
272 THE CORRELATION OF P53 AND P16 EXPRESSIONS AND ESOPHAGEAL CANCER PATIENTS ONE-YEAR SURVIVAL
285 TRPV2 AMPLIFICATION IN GASTRIC ADENOCARCINOMA
286 THE USE OF GASTRIC WASHES FOR THE IDENTIFICATION OF DNA MUTATIONS IN GASTRIC CANCER: IMPLICATIONS FOR LIQUID-BIOPSY AND PATIENT FOLLOW-UP
289 REG4 ACTIVATES THE MAPK-BIM-CASPASE3 SIGNALING PATHWAY IN 5-FLUOROURACIL RESISTANT GASTRIC CANCER
348 DETECTION HIGH-RISK HPV DNA IN CHAGASIC MEGAESOPHAGUS WITH AND WITHOUT CANCER
412 POSTGASTRECTOMY REDUCED ACUITY VISUAL WITH THIAMINE DEFICIENCY AND ALCOHOL ABUSE
483 EVALUATION OF HELICOBACTER PYLORI IN PERUVIAN RELATIVES OF GASTRIC CANCER PATIENTS
499 ABLATING CHALLENGING LIVER LESIONS: HOW TO GET THERE?
509 EPHB6 RECEPTOR NEGATIVELY REGULATES CHEMOTHERAPY SENSITIVITY AND GASTRIC CANCER CELL GROWTH BY SUPPRESSING ERK-MEDIATED BCL-2 EXPRESSION
512 ANALYSIS OF THE INDICATIONS OF PARAMAGNETIC HEPATOBILIARY CONTRAST AGENT (GD-DTPA-EOD) ON MRI AT A CANCER CENTER.
513 ATYPICAL PATTERNS OF LIVER LESIONS ON MRI WITH PARAMAGNETIC HEPATO-SPECIFIC CONTRAST AGENT (GD-DTPA-EOD).
529 VIRTUAL GASTROSCOPY ON GASTRIC CANCER STAGING
532 COMBINATION THERAPIES IN THE MANAGEMENT OF LARGE (≥ 5 CM) HEPATOCELLULAR CARCINOMA: MICROWAVE ABLATION IMMEDIATELY FOLLOWED BY TRANSARTERIAL CHEMOEMBOLIZATION
564 COULD ANTISENSE OLIGONUCLEOTIDES TARGETED TO K-RAS INHIBIT THE TUMOR GROWTH, INVASIVENESS AND EXPRESSION OF MMP-2 AND MMP-9 IN VITRO AND IN VIVO IN HAMSTER EXPERIMENTAL PANCREATIC CÂNCER MODEL?
600 DESMOPLASTIC SMALL ROUND CELL TUMOR: CASE REPORT
610 THE ANALYSIS OF ADVERSE EVENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION COMPARED WITH ENDOSCOPIC MUCOSAL RESECTION IN ERLY GASTRIC CANCER.
615 ASYMPTOMATIC INTESTINAL PNEUMATOSIS IN ONCOLOGIC PATIENTS
629 CYTOTOXIC ACTIVITY OF ANTITUMOR COMPOUND E-2-BENZO[D]THIAZOLE INDUCES APOPTOSIS AND INHIBITS MIGRATION IN DIFFUSE TYPE GASTRIC CANCER CELL LINE.
631 GREEN TEA EXTRACT COULD INHIBIT THE TUMOR GROWTH AND INVASIVENESS OF 5-FU AND MMC-RESISTANT METASTATIC AND REMETASTATIC CELL LINES IN A HAMSTER PANCREATIC CANCER MODEL
636 THE ANALYSIS OF ADVERSE EVENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION COMPARED WITH ENDOSCOPIC MUCOSAL RESECTION IN EARLY GASTRIC CANCER.
642 GALLBLADDER CARCINOMA: WHICH IS THE BEST METHOD TO DIAGNOSIS IN PATIENTS WITH ASYMPTOMATIC GALLBLADDER POLYPS?
647 FACTORS INFLUENCING KI67 CALCULATION IN NEUROENDOCRINE TUMORS
657 NIPPED-B HOMOLOG INCREASES THE SENSITIVITY OF CISPLATIN TO ESCC CELLS THROUGH THE HISTONE DEACETYLATION-DEPENDENT UPREGULATION OF PUMA.
93 H446 CELL GROWTH INHIBITION BY SONODYNAMIC THERAPY USING DVDMS
109 THE ANALYSIS OF INCIDENTAL RECEIPT OF BETA-BLOCKER MEDICINE AND OVERALL SURVIVAL OUTCOME AMONG PATIENTS WITH INOPERABLE NSCLC
127 FARNESOID X RECEPTOR PROMOTES METASTASIS OF NON-SMALL CELL LUNG CANCER BY TRANSCRIPTIONALLY ACTIVATING MMP-9
162 PROGNOSTIC GENE SIGNATURES FOR LUNG ADENOCARCINOMA USING DIGITAL MULTIPLEXED GENE EXPRESSION IN FORMALIN-FIXED PARAFFIN EMBEDDED TISSUE
197 PREDICTING PATHOLOGICAL EFFECTS USING THE TUMOR VOLUME REDUCTION RATE AFTER INDUCTION CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
209 COMPARATIVE STUDY OF PLAIN AND CONTRAST CT SCAN OF THORAX TO DETECT PULMONARY PARENCHYMAL METASTASES IN PATIENTS OF BONE AND SOFT TISSUE SARCOMAS.
210 SERUM LEVEL OF INTERLEUKIN-6 IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
253 DIAGNOSTIC VALUE OF PET / CT COMBINED WITH HRCT FOR THE PURE GROUND-GLASS NODULES
255 LACK OF BAP1 NUCLEAR STAINING MAY HELP IDENTIFY MESOTHELIOMA FROM OTHER MALIGNANCIES WITH SIMILAR MORPHOLOGY
300 THE CORRELATIVE STUDY BETWEEN EFFICACY OF PEMETREXED COMBINED PLATINUM CHEMOTHERAPY AND POLYMORPHISM OF TYMS、GSTP1 GENE IN ADVANCED NON-SMALL CELL LUNG CANCER
324 RAC1 OVEREXPRESSION IS CORRELATED WITH EPITHELIAL-MESENCHYMAL TRANSITION AND PREDICTS POOR PROGNOSIS OF NON-SMALL CELL LUNG CANCER
335 A NOMOGRAM TO PREDICT BRAIN METASTASES OF RESECTED NON-SMALL CELL LUNG CANCER PATIENTS
344 EXPRESSION OF VEGF IN NON-SMALL CELL LUNG CANCER AND ITS CORRELATION WITH PATHOLOGICAL CHARACTERISTICS
347 CYTOKINE-INDUCED KILLER(CIK) AS AN EFFECTIVE ADJUVANT THERAPY IN COMBINATION WITH CONVENTIONAL TREATMENTS IN NON-SMALL-CELL LUNG CANCER(NSCLC)
382 PLASMA THIOREDOXIN REDUCTASE 1 IS A POTENTIAL DIAGNOSTIC BIOMARKER FOR NON-SMALL CELL LUNG CANCE
444 CT-GUIDED BIOPSY OF SMALL PULMONARY SUBSOLID LESION: ACCURACY AND COMPLICATIONS
457 MUTATION DETECTION IN CIRCULATING FREE DNA (CFDNA) USING A TARGETED NEXT GENERATION SEQUENCING PLATFORM IN LUNG CANCER PATIENTS.
458 SAFETY IN MEDIASTINUM PERCUTANEOUS PROCEDURES. COMPILATION OF MAIN ACCESS ROUTES
526 ANALYSIS OF CHEST COMPUTED ANGIOTOMOGRAPHY EXAMS TO CONFIRM PULMONARY EMBOLISM PERFORMED AT THE EMERGENCY ROOM IN A PRIVATE ONCOLOGIC HOSPITAL IN SÃO PAULO.
547 MODIFIED COAXIAL TECHNIQUE AS AN OPTION IN CORE BIOPSIES OF CHALLENGING SMALL MEDIASTINAL LESIONS LOCATED NEAR THE LARGE VESSELS: THE “MARSHMALLOW” TECHNIQUE.
553 PERCUTANEOUS ACETABULOPLASTY WITH BALLOON AND CEMENT
596 THE ROLE OF ENDOBRONCHIAL ULTRASOUND COMBINED WITH TRANSBRONCHIAL NEEDLE ASPIRATION (EBUS-TBNA) IN THE DIAGNOSIS OF MEDIASTINAL LESIONS
625 PERCUTANEOUS CT-GUIDED BIOPSY (PCTGB) OF SMALL (< 2CM) SUBSOLID LESIONS IS CHALLENGING; BUT SAFE AND ACCURATE
663 CONCORDANCE BETWEEN IMMUNOHISTOCHEMISTRY (CLONE 5A4), ALK TESTING (CLONE D5F3-VENTANA®) AND FISH (VYSIS) IN PATIENTS WITH ADVANCED-STAGE LUNG ADENOCARCINOMA WITHOUT EGFR, KRAS OR BRAF MUTATIONS.
180 THE EXPRESSION OF MULTIDRUG RESISTANCE PROTEIN-1 IN CTCS IS A PREDICTOR OF FAILURE TO IRINOTECAN-BASED CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
188 DETECTION OF ERCC1 AND MRP-7 IN CIRCULATING TUMOR MICROEMBOLI FROM PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA AND THEIR RELATION WITH PROGRESSION FREE SURVIVAL
403 RENAL FUNCTION OF PATIENTS CANCER WITH DIABETES TYPE 1 AND 2 THAT WERE SUBJECT TO COMPUTED TOMOGRAPHY AFTER INJECTION OF IODINATED CONTRAST.
639 IMPROVED CLINICAL DECISION MAKING THROUGH STANDARDIZED CAPTURE AND ANALYSIS OF IMAGING DATA
SCIENTIFIC PROGRAM – POSTER SESSION 5
447 ADVANCING WOMEN FACULTY CAREERS AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER – AND BEYOND
29 THE RELATIONSHIP BETWEEN CIRCUMCISION AND HUMAN PAPILLOMAVIRUS INFECTION
147 ASSOCIATION BETWEEN INTRAVAGINAL CLEANSING AND REDUCED CERVICO-VAGINAL HUMAN PAPILLOMAVIRUS INFECTION AMONG FEMALE SEX WORKERS IN CAMBODIA
219 AN ANALYZE OF ONE DECADE OF SKIN CANCER PREVENTION PROGRAM USING A MOBILE UNIT
349 BRUSH CYTOLOGY ANALYSIS FOR THE DIAGNOSIS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA
398 THE VARIATIONS OF T-LYMPHOCYTES IN HEPATOCELLULAR CARCINOMA INDUCED BY DIETHYLNITROSAMINE IN SD RAT MODEL
401 METHYLATION PROFILE OF GENES IN PRECURSOR LESIONS OF CERVICAL CANCER
451 EFFECTIVE DOSE ASSESSMENT USED IN CANCER PATIENTS THE PROTOCOL GASTROSCOPY VIRTUAL IN COMPUTED TOMOGRAPHY.
462 THE EFFECTIVE DOSE OF THORAX LOW DOSE PROTOCOL ASSESSMENT COMPUTED TOMOGRAPHY FOR SCREENNING WITH LUNG CANCER COMPARED WITH THORAX ROUTINE EXAMINATION.
465 ABERRANT PLASMA LEVELS OF CIRCULATING MIR-21 AND MIR-494 ARE ASSOCIATED WITH A POOR PROGNOSIS IN PATIENTS WITH BREAST CANCER.
471 CAN THE SCHOOLING LEVEL BE USED AS PROGNOSTIC FACTOR IN CERVICAL CANCER?
504 METHYLATION STATUS ANALYSIS OF PROMOTER REGIONS OF MALM1 AND MALM2 GENES AS SCREENING HIGH-RISK HUMAN PAPILLOMAVIRUS POSITIVE PATIENTS
520 ANALYSIS OF RKIP EXPRESSION IN CERVICAL CYTOLOGY SAMPLES AS A MARKER FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
617 DESCRIPTIVE ANALYSES OF BRCA1/2 MUTATION CARRIERS AT HOSPITAL DE CÂNCER DE BARRETOS
624 DESCRIPTIVE ANALYSES OF MMR GERMLINE MUTATION CARRIERS AT HOSPITAL DE CÂNCER DE BARRETOS
634 DESCRIPTIVE ANALYSES OF PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS AT HOSPITAL DE CÂNCER DE BARRETOS
252 MIR-221TARGETS HMGA2 TO INHIBITBLEOMYCIN-INDUCED PULMONARYFIBROSIS BY REGULATING TGF-Β1/SMAD3 INDUCED EMT
493 “ONCOLOGIC EMERGENCIES”
533 RETROSPECTIVE ANALYSIS OF PERCUTANEOUS NEPHROSTOMIES IN CANCER PATIENTS.
597 SUPERIOR VENA CAVA SYNDROME: 3 CASES, MANY LESSONS LEARNED
350 BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY FOR THE ELDERLY PATIENTS WITH ACRC: A SYSTEMATIC REVIEW AND META-ANALYSIS OF COMPARATIVE STUDIES
159 HYPERBARIC OXYGEN AS THE WAY TO OVERCOME THE PROBLEM OF HYPOXIA-INDUCED PROTECTION OF GLIOBLASTOMA CELLS AGAINST MODIFIED ISOTHIOUREA DERIVATIVE (ZKK-3)
265 MICROARRAY ANALYSIS OF POLYSOME ASSOCIATED MRNAS FROM A HUMAN GLIOBLASTOMA REVEALS INTRATUMORAL HETEROGENEITY.
299 HIGH MYC PROTEIN EXPRESSION PREDICTS UNFAVORABLE SURVIVAL FOR PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B-CELL LYMPHOMA (PCNS-DLBCL)
301 ANTI-NEOPLASTIC POTENTIAL OF BRAZILIAN PLANTS CRUDE EXTRACT ON HUMAN GLIOMA CELL LINES
371 LOSS OF MTAP EXPRESSION IS ASSOCIATED WITH POOR PROGNOSIS IN GLIOMA PATIENTS
378 ROLE OF WNK2 ON GLIOMA CELLS ENDOCYTOSIS PATHWAY.
517 EVALUATION OF COMPUTED TOMOGRAPHY EXAMS OF SKULL PERFORMED IN A HOSPITAL EMERGENCY ONCOLOGICAL.
579 MOLECULAR CHARACTERIZATION OF BRAZILIAN IMMORTALIZED GLIOBLASTOMA CELL LINES
618 THE ROLE OF STRESS INDUCIBLE PROTEIN 1 IN BRAIN TUMOR ANGIOGENESIS
641 METHYLATION OF MGMT IN PERUVIAN CASES OF GLIOBLASTOMA: VALIDATION OF EPIGENETIC TECHNIQUE
468 DEVELOPMENT AND IMPLEMENTATION OF A PROGRAM FOR INDIVIDUALS AT HIGH RISK FOR BREAST CANCER AT CLINICA ALEMANA, SANTIAGO CHILE
469 BRCA 1-2 FULL GENE SEQUENCE + LARGE REARRANGEMENTS OR PANEL GENETIC TESTING ? CLINICA ALEMANA BREAST CANCER RISK EVALUATION UNIT INITIAL EXPERIENCE.
475 GENE PREDICTIVE SIGNATURE ASSOCIATED WITH DUCTAL CARCINOMA IN SITU PROGRESSION TO INVASIVE BREAST CANCER
476 MR IMAGING IN EVALUATION OF PAGET DISEASE OF THE BREAST: A PICTORIAL ESSAY
477 ANALYSIS OF 159 INDETERMINATE BREAST LESIONS WITH ULTRASOUND ELASTOGRAPHY IN AN ONCOLOGY CENTER
485 IMAGING APPEARANCES OF MALE BREAST CANCER: A PICTORIAL ESSAY
496 BETTER TIMING OF SURGICAL AXILLARY STAGING FOR HER2-OVEREXPRESSED BREAST CANCER: BEFORE OR AFTER NEOADJUVANT CHEMOTHERAPY (NAC)?
503 ASSESSING GENOMIC INSTABILITY AND GLOBAL METHYLATION IN SPORADIC AND HEREDITARY TRIPLE-NEGATIVE BREAST TUMORS
516 EXTENSIVE SEARCHING FOR BREAST CANCER SPLICING VARIANTS REVEALED A PROTEIN ISOFORM OF TRIM37 AS A POTENTIAL BIOMARKER WITH CLINICAL RELEVANCE
523 GENE EXPRESSION PROFILING OF BREAST CANCER IN LEBANESE WOMEN
556 THE INFLUENCE OF INTERNATIONAL STUDIES ON THE REALITY OF SUS IN BRAZIL: SENTINEL LYMPH NODE WITHOUT TRANS-OPERATIVE EXAMINATION
561 NIPPLE SPARING MASTECTOMY: CURRENT SCENARIO
598 [ROLE OF DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING IN THE DIAGNOSTIC OF BREAST LESIONS]
633 RISK OF INVASIVE CARCINOMA AMONG OBESE WOMAN WITH LOBULAR CARCINOMA IN SITU.
638 DESORPTION ELECTROSPRAY IONIZATION MASS SPECTROMETRY (DESI-MS) IN BREAST CANCER
640 LI-FRAUMENI SYNDROME IN FEMALES WITH EARLY ONSET BREAST CANCER IN A MEXICAN POPULATION.
652 ITADE FLAP: A GOOD CHOICE FOR MID-SIZED DEFECTS OF THE CHEST WALL
654 BREAST CANCER SCREENING IN DEVELOPING COUNTRIES. A SYSTEMATIC REVIEW.
655 EXPRESSION OF MTSS1, RPL37A, HTRA1 AND ITS RELATIONSHIP WITH THE COMPLETE PATHOLOGICAL RESPONSE AND SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED BREAST CARCINOMA SUBMITTED TO NEOADJUVANT CHEMOTHERAPY.
666 RS1008805 POLYMORPHISM IN THE CYP19A1 GENE IS ASSOCIATED WITH THE PROGNOSIS OF STAGE I-II AND OPERABLE STAGE III BREAST CANCER
667 RS1008805 POLYMORPHISM IN CYP19A1 GENE IS RELATED TO THE EFFICACY OF HORMONE THERAPY IN STAGE I–II AND OPERABLE STAGE III BREAST CANCER
668 HIGH CIRCULATING CONCENTRATIONS OF HER2 EXTRACELLULAR DOMAIN (ECD) EXHIBITS A POOR PROGNOSTIC IMPACT ON METASTATIC BREAST CANCER PATIENTS
102 CHINESE ONCOLOGISTS’ KNOWLEDGE, ATTITUDES AND PRACTICE TOWARDS PALLIATIVE CARE AND END OF LIFE ISSUES
146 MICRORNA PROFILES IN METASTATIC VERSUS NON-METASTATIC SALIVARY MUCOEPIDERMOID CARCINOMA
177 SEMEN BANK PROFILE: SPERM CRYOPRESERVATION IS ALWAYS INDICATED FOR PATIENTS UNDERGOING CANCER TREATMENT?
178 HOW LONG A SPERM SAMPLE CAN REMAIN CRYOPRESERVED?
245 CHARACTERISTICS OF INVASIVE ASPERGILOSIS CASES IN STEM CELL TRANSPLANTATION SCENARIO
473 FOOD CONSUMPTION AND HEAD AND NECK CANCER IN THREE BRAZILIAN CAPITALS – INTERCHANGE STUDY
488 TRANSLATIONAL NETWORK IN TAIWAN: PREDICTIVE, PREVENTIVE, PERSONALIZED AND PARTICIPATORY CANCER RESEARCH
489 THE UNIQUE GENOMIC PREDICTIVE MARKERS FOR TAIWAN HEAD AND NECK CANCERS
490 SEARCHING FOR THE CAVEOLIN-1 AND CYCLOOXYGENASE 2 GENOMIC MARKERS FOR KIDNEY, URETER, BLADDER AND PROSTATE CANCERS IN TAIWAN
511 ROUTINE ANALYSIS OF BRCA1 AND BRCA2 GENES IN AN ISRAELITE BRAZILIAN HOSPITAL: RESULTS AND PECULIAR CLINICAL FINDINGS
542 ANALYSIS OF ‘’HERBAL/ALTERNATIVE MEDICINE‘’ TRIALS SUBMITTED TO CLINICALTRIALS.GOV DATABASE
563 AMPUTATIONS IN BONE SARCOMA: WHO? WHY? HOW?
603 THE PEDIATRIC ONCOLOGY EXPERIENCE AT HOSPITAL ISRALEITA ALBERT EINSTEIN
648 DEVELOPMENT AND VALIDATION OF THE WEB-BASED PATIENT-REPORTED OUTCOMES CAPTURE SYSTEM- NEEDS, ACCEPTANCE AND READINESS ASSESSMENT (WPROCS-NARA) QUESTIONNAIRES
SCIENTIFIC PROGRAM – POSTER SESSION 6
124 FACIAL LYMPH NODE INVOLVEMENT AS A PROGNOSTIC FACTOR FOR SURVIVAL IN ORAL CAVITY SQUAMOUS CELL CARCINOMA
170 EXOSOMAL DELIVERY OF MIR-24-3P IMPEDES T-CELL PROLIFERATION AND DIFFERENTIATION BY REPRESSING FGF11 AND CORRELATES WITH PROGNOSIS IN NASOPHARYNGEAL CARCINOMA
187 MULTIPHASE ENHANCEMENT PATTERNS OF METASTATIC CERVICAL NODES ON MULTIDETECTOR COMPUTED TOMOGRAPHY (4D-MDCT)
205 SIGNIFICANCE OF SERUM PHOSPHORUS, AND VITAMIN D IN PAPILLARY THYROID CANCER PATIENTS IN THE EASTERN COASTAL CHINA
208 CLINICOPATHOLOGICAL ANALYSIS OF THYROID NEOPLASMS WITH PREOPERATIVE RECURRENT LARYNGEAL NERVE PALSY IN 80 CASES
226 MIR-320B-TARGETED TRIAP1 PREVENTS MITOCHONDRIA FRAGMENTATION AND APOPTOSIS BY CONTROLLING CYTOCHROME C RELEASE IN NASOPHARYNGEAL CARCINOMA
233 MIR-195 SUPPRESSES THE THYOID CANCER BY TARGETED RAF1
242 LONG-TERM USE OF NIMOTUZUMAB IN COMBINATION WITH INTENSITY-MODULATED RADIOTHERAPY AND CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA:EXPERIENCE OF A SINGLE INSTITUTION
261 THE UTILITY OF MONITORING MICROSURGICAL FLAPS
267 APOPTOTIC SIGNALING IN HUMAN SALIVARY GLAND DEVELOPMENT
268 EPITHELIAL-MESENCHYMAL TRANSITION (EMT) DURING SALIVARY GLAND TUMORIGENESIS: EXPRESSION OF E-CADERIN AND C-KIT
290 WHOLE EXOME SEQUENCING ANALYSIS OF NOTCH PATHWAY GENE MUTATIONS IN SALIVARY MUCOEPIDERMOID CARCINOMAS
331 INTEGRATIVE ANALYSIS OF EXPRESSION AND DNA METHYLATION DATA REVEAL PUTATIVE MOLECULAR DRIVERS IN PAPILLARY THYROID CANCER
338 GLOBAL GENE EXPRESSION PROFILE IN THE PROGRESSION OF ORAL PROLIFERATIVE VERRUCOUS LEUKOPLAKIA.
363 INNOVATIVE PALLIATIVE TREATMENT IN ADVANCED HEAD AND NECK CANCER
375 MIR-451 EXPRESSION IMPACTS KEY BIOLOGICAL PROCESSES THROUGH REGULATION OF PI3K/AKT PATHWAY AND HIGHER THERAPY SENSITIVITY WITH INHIBITOR ANTI-EGFR ALLITINIB IN HUMAN HEAD AND NECK CANCER CELL LINES
377 PROGNOSTIC VALUE OF TUMORAL NK CELLS AND T CELLS SPECIFIC SUBSETS IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA
385 ASSOCIATION OF PIM-1 EXPRESSION WITH TUMOR PROGRESSION AND PATIENTS’ PROGNOSIS IN SALIVARY GLAND ADENOID CYSTIC CARCINOMA
413 RNA-SEQ REVEALS TRANSCRIPTIONAL DIFFERENCES BETWEEN EARLY STAGE METASTATIC AND ADVANCED STAGE NON-METASTATIC ORAL SQUAMOUS CELL CARCINOMAS
472 THE IMPACT OF RAB7 EXPRESSION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PROGRESSION
480 SECOND AND THIRD TUMORS IN PATIENTS WITH HEAD AND NECK CANCER.
481 UTILITY OF FROZEN SECTION IN THE DIAGNOSIS
486 FREE FLAP RECONSTRUCTION OF HEAD AND NECK DEFECTS AFTER ONCOLOGIC RESECCION IN THE INSTITUTE OF CANCER AMERICAS CLINIC. MEDELLIN COLOMBIA. OUTCOMES IN 50 CASES
502 ALCOHOLIZATION OF METASTATIC CERVICAL LYMPH NODES IN THYROID TUMORS
515 SCREENING OF GENOMIC ALTERATIONS IN HEAD AND NECK CARCINOMAS OF YOUNG PATIENTS BY TOTAL EXOME SEQUENCING.
518 PERCUTANEOUS BIOPSY GUIDED BY CT RETROBULBAR TUMORS : EXPERIENCE OF A CANCER CENTER
545 CT-GUIDED GASTROSTOMY: INICIAL EXPERIENCE IN A BRAZILIAN CANCER CENTER
549 CORE-NEEDLE BIOPSIES OF RETROBULBAR TUMORS: EXPERIENCE IN A BRAZILIAN CANCER CENTER
571 MIRNA GENES REGULATED BY DNA METHYLATION IN PAPILLARY THYROID CARCINOMAS
601 CIRCULATING TUMOR MICROEMBOLI (CTM) AS PROGNOSTIC FACTOR FOR PATIENTS WITH HEAD AND NECK ADVANCED SQUAMOUS CELL CARCINOMA (HNSCC)
613 METHYLATION PROFILE OF FOLLICULAR CELL DERIVED THYROID LESIONS
664 PI3K MUTATIONAL STATUS IN ORAL SQUAMOUS CELL CARCINOMA.
157 OVERALL SURVIVAL AMONG OLDER PATIENTS WITH SOLID TUMORS
166 EFFICACY AND TOLERABILITY OF 20MG CONTROLLED-RELEASE OXYCODONE TABLETS IN OPIOID-NAÏVE CANCER PAIN PATIENTS WITH NRS HIGHER THAN 6
251 A CLINICAL PLACEMENT PROGRAM FOR PRIMARY CARE PROFESSIONALS AT A COMPREHENSIVE CANCER CENTRE
332 STUDY OF THE QUALITY OF LIFE IN PATIENTS WITH PROSTATE ADENOCARCINOMA COMPARED TO INDIVIDUALS OF THE SAME AGE WITHOUT THIS PATHOLOGY.
479 IMPACT OF DELIRIUM ON SYMPTOM DISTRESS AND SURVIVAL OF ADVANCED CANCER PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT: A PROSPECTIVE RANDOMIZED STUDY
522 PERCEPTION OF CURABILITY AMONG ADVANCED CANCER PATIENTS RECEIVING PALLIATIVE CARE AROUND THE WORLD
562 BRAZILIAN KNEE TUMOR PROSTHESIS: SURVIVORSHIP ANALYSIS AND OUTCOMES
464 A MOBILE PHONE PLATFORM FOR CANCER PATIENT EVALUATION AND FOLLOW UP IN SUBSAHARAN AFRICA